deltatrials
Not Yet Recruiting OBSERVATIONAL NCT05960864

Chinese Spondyloarthritis Inception Cohort (CESPIC) (CESPIC)

Chinese Spondyloarthritis Inception Cohort

Sponsor: Southwest Hospital, China

Interventions Celecoxib
Updated 5 times since 2023 Last updated: Apr 16, 2024 Started: Sep 30, 2024 Primary completion: Aug 31, 2025 Completion: Aug 31, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05960864, this observational or N/A phase trial focuses on Acute Anterior Uveitis (AAU) and Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA) and remains actively recruiting participants. Sponsored by Southwest Hospital, China, it has been updated 5 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Aug 2023 – ~Dec 2023 · 4 months · monthly snapshotNot Yet Recruiting~Dec 2023 – ~May 2024 · 5 months · monthly snapshotNot Yet Recruiting~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotNot Yet Recruiting

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Not Yet Recruiting

  2. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting

  3. May 2024 — Jul 2024 [monthly]

    Not Yet Recruiting

  4. Dec 2023 — May 2024 [monthly]

    Not Yet Recruiting

  5. Aug 2023 — Dec 2023 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Southwest Hospital, China
Data source: Southwest Hospital, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.